zol-4-yl-)ethyl amine (L imz 1), have been synthesized. The corresponding copper(I) complexes [Cu(I)(L OL 1)(CH3CN)]PF6 (CuL OL 1), [Cu(I)(L OL 2)(CH3CN)]PF6 (CuL OL 2), [Cu(I)(L OL 3)(CH3CN)]PF6 (CuL OL 3), [Cu(I)(L imz 1)(CH3CN)2]PF6 (CuL imz 1) as well as the Cu(I) complex derived from the known ligand bis(1-methylimidazol-2-yl)methane (BIMZ), [Cu(I)(BIMZ)(CH3CN)]PF6 (CuBIMZ), are screened as catalysts
四个基于
咪唑的新
配体,4-(((
1H-咪唑-4-基)甲基)-2-苯基-4,5-二氢氧基唑(L OL 1),4-((
1H-咪唑-4-基)甲基)-2-(叔丁基)-4,5-二氢唑(L OL 2),4-(((
1H-咪唑-4-基)甲基)-2-甲基-4,5-二氢唑(L OL 3)合成了N-(2,2-二甲基亚丙基)-2-(1-三苯甲基-
1H-咪唑-4-基-)
乙胺(L
IMZ 1)。相应的
铜(I)络合物[Cu(I)(L OL 1)(CH3CN)] PF6(CuL OL 1),[Cu(I)(L OL 2)(CH3CN)] PF6(CuL OL 2),[ Cu(I)(L OL 3)(CH3CN)] PF6(CuL OL 3),[Cu(I)(L
IMZ 1)(CH3CN)2] PF6(CuL
IMZ 1)以及Cu(I)络合物衍生自已知
配体双(1-甲基
咪唑-2-基)
甲烷(B
IMZ)的[Cu(I)(B
IMZ)(CH3CN)]